ATS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ATS Corp is not a clear buy right now for a Beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock has solid longer-term business positives, but the current technical setup is mixed-to-weak after a sharp market drop, and the latest quarter showed strong revenue growth while order bookings fell. Since there is no strong Intellectia buy signal today and the stock is sitting below key resistance with negative momentum, the better call is to hold and wait for a cleaner entry rather than buy immediately.
The technical picture is mixed. Price is 31.05 after a steep regular-session drop of 13.72%, which signals immediate weakness. MACD histogram is -0.134 and worsening, so momentum is still negative. RSI_6 at 30.61 is near oversold but not a strong reversal signal yet. The moving averages are bullish in structure with SMA_5 > SMA_20 > SMA_200, which supports the longer-term trend, but the stock is trading below pivot 32.383 and below resistance levels R1 35.164 and R2 36.882. Key support is near 29.602, so downside risk remains if that level breaks. The short-term pattern probabilities are mildly positive, but not strong enough to justify an immediate long-term buy after the recent drop.
ATS reported strong quarterly revenue growth, including 30.1% year-over-year revenue growth to $747.1 million and full-year revenue up 11%. Non-GAAP EPS of $0.36 beat expectations, which is a positive earnings catalyst. The company also has a strong backlog of $2 billion, which supports future revenue visibility. Scotiabank recently raised its price target to C$51 and kept an Outperform rating, showing some bullish analyst support. The low put-call ratio also suggests some underlying market optimism.
Q4 order bookings fell 18%, which is the clearest fundamental concern in the latest update. Goldman Sachs recently lowered its price target to $30 and kept a Sell rating, showing a bearish analyst view. The stock also suffered a sharp daily decline, and MACD momentum is negative. No AI Stock Picker or SwingMax buy signal is present today, so there is no proprietary catalyst supporting an immediate entry. Insider and hedge fund activity are both neutral, with no meaningful recent accumulation signal. No recent congress trading data is available.
The latest quarter appears to be Q4. In that quarter, ATS delivered 30.1% year-over-year revenue growth to $747.1 million and Non-GAAP EPS of $0.36, both supportive of operational strength. For the full year, revenue increased 11%, which indicates healthy top-line growth. The main weakness is that Q4 order bookings declined 18%, suggesting some softness in future demand despite the strong backlog of $2 billion. Overall, recent financial performance is good on growth and earnings, but bookings weakness makes the outlook less compelling for an immediate buy.
Analyst sentiment is mixed. On 2026-04-28, Scotiabank raised its price target to C$51 from C$48 and maintained an Outperform rating, which is bullish. On 2026-04-07, Goldman Sachs lowered its target to $30 from $31 and kept a Sell rating, which is bearish. The current Wall Street view is divided, with one major firm positive on long-term value and another clearly negative on the stock. That split argues for caution rather than aggressive buying at the current price.
